Celgene to Present New Data from Clinical Trials on Oral OTEZLA…

Celgene Corporation today announced that findings from ongoing clinical trials of OTEZLA , the Company’s oral, selective inhibitor of phosphodiesterase 4 , conducted in patients with moderate or moderate to severe plaque psoriasis, and in adult patients with active psoriatic arthritis, will be presented at the 75th Annual Meeting of the American Academy of Dermatology in Orlando, Florida. Ten abstracts will be presented at the meeting.

National Cancer Prevention Month

… to informing the Marco Island community about the American Cancer Society, the nationwide community-based voluntary health organization dedicated to eliminating cancer as a major health concern by preventing cancer, saving lives, and diminishing …

A dermatoscope, like that introduced in York.

… which can examine skin lesions in detail, are an essential tool for dermatologists, general practitioners and other health professionals attempting early diagnosis of melanoma. Dr Dan Cottingham, GP MacMillan cancer lead for Vale of York Clinical …

Dermatologist Explains Tanning Risks As Bill Advances

A bill that would keep Arkansans under the age of 18 from tanning has now reached the Arkansas house floor for voting. According to the American Academy of Dermatology, skin cancer is the most common form of cancer and dermatologists are seeing an increase right here in the River Valley.

AI System Recognizes Skin Cancer

… as successfully as human experts, according to the latest research attempting to apply artificial intelligence to health. The US-based researchers say the new system, which is based on image recognition, could be developed for smartphones, …

Could your smartphone catch skin cancer?

Scientists at Stanford University in the US trained the deep-learning algorithm, developed by Google and known as a neural net, to visually diagnose potential cancers. A study, published in the journal Nature, showed that when tested on nearly 130,000 images, it detected malignant cancers with 91 per cent accuracy.

Deep Learning Algorithm Diagnoses Skin Cancer As Well As Seasoned Dermatologists

An anonymous reader quotes a report from ExtremeTech: Remember how that Google neural net learned to tell the difference between dogs and cats ? It’s helping catch skin cancer now, thanks to some scientists at Stanford who trained it up and then loosed it on a huge set of high-quality diagnostic images. During recent tests, the algorithm performed just as well as almost two dozen veteran dermatologists in deciding whether a lesion needed further medical attention.

Deep Learning Algorithm Diagnoses Skin Cancer As Well As Seasoned Dermatologists

An anonymous reader quotes a report from ExtremeTech: Remember how that Google neural net learned to tell the difference between dogs and cats ? It’s helping catch skin cancer now, thanks to some scientists at Stanford who trained it up and then loosed it on a huge set of high-quality diagnostic images. During recent tests, the algorithm performed just as well as almost two dozen veteran dermatologists in deciding whether a lesion needed further medical attention.

New NMRMC dermatology clinic opens

Dermatologist P. Christy Parham-Vetter, MD, said the day started a little slowly, but she has a great staff and patients were understanding. Vetter said there are not enough dermatologists to go around anywhere, particularly in rural areas.

Skin cancer drop in Northeast bucks rising rates elsewhere

This photo provided by the American Academy of Dermatology shows a typical presentation of a suspicious mole that eventually was diagnosed as melanoma. A study released Wednesday, Dec. 28, 2016, suggests a decline in melanoma cases and deaths in Northeast states buck a national trend for the deadliest skin cancer and may reflect the benefits of strong prevention programs.

Glenmark Unveils its Strategic Blueprint for Transition Into an…

The Blueprint conveys the company’s greater business alignment, expanding generics to prioritizing research and development efforts in three key therapeutic areas: oncology, respiratory and dermatology. The innovative oncology pipeline, with candidates targeting multiple tumors, is the top priority with the greater promise to deliver novel, first-in-class molecules and help Glenmark evolve into a fully commercialized, innovation-led pharmaceutical company.